Max Drawdown (5Y) Chart

Historical Max Drawdown (5Y) Data

View and export this data back to 1992. Start Trial.
Date Value
September 30, 2026 45.32%
August 31, 2026 45.32%
July 31, 2026 45.32%
June 30, 2026 45.32%
May 31, 2026 45.32%
April 30, 2026 41.21%
March 31, 2026 39.51%
February 28, 2026 30.02%
January 31, 2026 29.43%
December 31, 2025 29.43%
November 30, 2025 29.43%
October 31, 2025 29.43%
September 30, 2025 36.06%
August 31, 2025 39.14%
July 31, 2025 39.14%
June 30, 2025 39.14%
May 31, 2025 39.14%
April 30, 2025 41.08%
March 31, 2025 53.88%
February 28, 2025 60.66%
January 31, 2025 60.66%
December 31, 2024 60.66%
November 30, 2024 60.66%
October 31, 2024 61.42%
September 30, 2024 68.68%
Date Value
August 31, 2024 68.68%
July 31, 2024 68.68%
June 30, 2024 68.68%
May 31, 2024 68.68%
April 30, 2024 68.68%
March 31, 2024 68.68%
February 29, 2024 68.68%
January 31, 2024 68.68%
December 31, 2023 68.68%
November 30, 2023 68.68%
October 31, 2023 68.68%
September 30, 2023 68.68%
August 31, 2023 68.68%
July 31, 2023 68.68%
June 30, 2023 68.68%
May 31, 2023 68.68%
April 30, 2023 68.68%
March 31, 2023 68.68%
February 28, 2023 68.68%
January 31, 2023 68.68%
December 31, 2022 68.68%
November 30, 2022 68.68%
October 31, 2022 68.68%
September 30, 2022 68.68%
August 31, 2022 68.68%

Max Drawdown Definition

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Baxter International, Inc. 80.60%
DexCom, Inc. 66.32%
Abbott Laboratories 39.63%
AngioDynamics, Inc. 82.98%
Alphatec Holdings, Inc. 73.51%